US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Stem Cell: market research reports

Stem cells are unique in that they are undifferentiated cells that can differentiate to become virtually any type of cell in the body (totipotent). They therefore represent an ongoing source of the specialized cells that make up the tissues and organs. There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies.
Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells.

Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.

RSS Feeds

Stem Cell market research reports and industry analysis

< prev 1    3  4  5  
Cancer Stem Cells Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ...  |  read more...
USD 6,746
EpiCast Report: Graft-Versus-Host Disease - Epidemiology Forecast to 2023
7/1/2014 | published by: GlobalData
... attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). Both aGVHD and cGVHD commonly affect organs such as the skin, gastrointestinal ...  |  read more...
USD 3,995
Regenerative Medicine Market in the US : 2014-2018
6/30/2014 | published by: TechNavio - Infiniti Research Ltd.
... Baxter International Inc., Johnson and Johnson Ltd., Kinetic Concepts Inc., Medtronic Inc., Stryker Corp., Aastrom Biosciences Inc., Acologix Inc., Advanced Cell Technology Inc., Arteriocyte Inc., Athersys Inc.,AvitaMedical Ltd., Bacterin International Inc., Bellicum Pharmaceuticals Inc., Bioactive ...  |  read more...
USD 3,000
Stem Cells - 6 Dimensional Assessment (Technical Insights)
6/27/2014 | published by: Frost & Sullivan
... potential to develop into many different cell types in the body during early life and growth. Indeed, under certain physiologic conditions they can be induced to become tissue or organ-specific cells with particular functions, thus ...  |  read more...
USD 6,500
Induced Pluripotent Stem Cells: Global Markets
6/1/2014 | published by: BCC Research
... market is expected to reach $2.9 billion in 2018, an estimated compound annual growth rate (CAGR) of 19.7% for the five-year period 2013 to 2018. This report provides: An overview of the global market for ...  |  read more...
USD 6,650
Update: Stem Cells Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Stem Cells in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 720
Stem Cell Research Products - Opportunities, Tools, and Technologies
5/1/2014 | published by: BioInformant Worldwide, L.L.C.
... discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first successful culturing of embryonic stem cells from non-human primates occurred and not ...  |  read more...
USD 3,495
Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014
4/30/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020
4/23/2014 | published by: MarketsandMarkets
... stem cell therapy market is estimated to grow at a lower CAGR in developed countries as compared to emerging countries such as China, India, and Korea in the forecast period (2015-2020). Factors such as increasing ...  |  read more...
USD 4,650
Pharma Leader Series: Top Stem Cell Technology Companies 2014-2024
3/17/2014 | published by: Visiongain
... sales potentials? Visiongain's new report shows you their outlooks from 2014. There you discover therapies, sales results, trends, opportunities, and predictions of revenues. That way you find data and analysis on cellular technologies with potential ...  |  read more...
USD 11,618
Circulating Tumor Cells and Cancer Stem Cells Technologies
3/1/2014 | published by: Global Industry Analysts
... US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics ...  |  read more...
USD 4,950
High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr
2/4/2014 | published by: MarketsandMarkets
... CRO) - Forecast to 2018 “Technological Advancements and Flourishing Outsourcing Industry Likely to Propel the Growth of the Global High Throughput Screening (HTS) Market” In this report, the global high throughput screening (HTS) market has ...  |  read more...
USD 4,650
Complete 2013-14 Induced Pluripotent Stem Cell Industry Report
2/1/2014 | published by: BioInformant Worldwide, L.L.C.
... replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics have caused great commercial interest, with potential applications ranging from ...  |  read more...
USD 3,495
Cell Therapy Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
MediPoint: Bone Grafts and Substitutes - South American Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
... has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents ...  |  read more...
USD 4,450
MediPoint: Bone Grafts and Substitutes - APAC Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
... resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents the ...  |  read more...
USD 4,450
MediPoint: Bone Grafts and Substitutes - EU Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
... resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents the ...  |  read more...
USD 4,450
Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018
1/6/2014 | published by: MarketsandMarkets
... years, the mice model market, which includes models and services, has witnessed many innovations that have led to an increase in the application areas of mice models. For instance, mice models are widely used in ...  |  read more...
USD 5,650
Neural Control Trends
1/1/2014 | published by: Global Industry Analysts
... the prospective application areas. In addition, the report also expounds the drawbacks of cyborg insects. Neural control, also known as neural interaction or neural interfacing, is touted to emerge as a revolutionary technology and a ...  |  read more...
USD 950
Cancer Stem Cell Trends
1/1/2014 | published by: Global Industry Analysts
... of diseases such as cancer and the reimbursement assistance by regulatory organizations in developed nations including the US and Europe. Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of ...  |  read more...
USD 1,450
Analyzing the Biotechnology Industry in India
1/1/2014 | published by: Aruvian's R'search
... the country's biotech industry, the Indian biotechnology market has witnessed remarkable growth in recent years. The biotech industry in India did not bear the brunt of the recent economic recession and in fact due to ...  |  read more...
USD 500
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets
1/1/2014 | published by: BCC Research
... reach nearly $8.9 billion by 2018, demonstrating a compound annual growth rate (CAGR) of 18.9% for the five-year period, 2013 to 2018. This report provides: An overview of the global market for cancer diagnostics based ...  |  read more...
USD 6,650
Mesenchymal Stem Cells
1/1/2014 | published by: Global Industry Analysts
... Annual estimates and forecasts are provided for the period 2009 through 2018. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. ...  |  read more...
USD 4,950
Plunkett's Health Care Technologies Overview 2014: A Summary Excerpted from Plunkett's Health Care Industry Almanac 2014
11/12/2013 | published by: Plunkett Research, Ltd.
... Research Online Link to our 5-minute video overview of this industry Pages: 76 Statistical Tables Provided: 40 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2014, including forecasts ...  |  read more...
USD 199
Plunkett's Health Care Industry Trends & Statistics 2014: A Summary Version of Plunkett's Health Care Industry Almanac 2014
11/12/2013 | published by: Plunkett Research, Ltd.
... at Plunkett Research Online Link to our 5-minute video overview of this industry Pages: 79 Statistical Tables Provided: 40 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2014, ...  |  read more...
USD 199
< prev 1    3  4  5